Alder Hey children’s hospital and Proveca announce collaboration

Alder Hey children’s hospital and Proveca Ltd are joining forces with the aim of improving medicines for children and young people. The new collaborative partnership plans to provide the best pharmaceutical treatments for children by identi...

Monument Therapeutics raises additional £0.5 million to take anti-neuroinflammation candidate MT1980 into clinic

Lipid reformulation of anti-inflammatory compound MT1980 for POCD accelerating into clinic in 2022 Manchester, UK, Dec 14, 2021: Monument Therapeutics, a stratified medicine company, today announced it has raised an additional £0....

INFEX Therapeutics agrees partnership with Colibri Scientific to provide services for RESP-X program

Alderley Park, Cheshire Infex Therapeutics has today announced a deal with Colibri Scientific, to provide logistics and sample operational services for Infex’s RESP-X program. RESP-X is an anti-virulence therapy in-licensed from Japane...

Panthera Biopartners leads the way in the UK with specialist research sites for NASH and NAFLD studies

With access to leading hepatologists, biopsy theatres, fibroscans at specialist sites and ongoing mass screening programmes Panthera can help pharma and CROs find a treatment for this increasingly common, progressive, and life-threatening diseases...

INFEX Therapeutics scientists achieve breakthrough with potential new drug for Omicron and new coronavirus strains

Alderley Park, Cheshire –  One of the UK’s leading infectious disease biotech companies has announced a breakthrough in laboratory trials of a new drug to treat COVID-19 and new variants of the disease, such as the Omicron variant...

From our portfolio


Medical Devices

viewview our portfolio

Our Team

Sarah Cooper

view complete team

Contact us

Tel: 01625 344300